Could stroke trials be missing important treatment effects?

被引：28

作者：

Berge, E

Barer, D ^{[1
]}

机构：

[1] Queen Elizabeth Hosp, Stroke Res Team, Gateshead NE9 6SX, England

[2] Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland

来源：

CEREBROVASCULAR DISEASES | 2002年 / 13卷 / 01期

关键词：

D O I：

10.1159/000047752

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

收藏

页码：73 / 75

页数：3

相关论文

共 8 条

[1] Clinical trials - Simple megatrials are not sufficient
Barer, D
[J]. BRITISH MEDICAL JOURNAL, 1999, 318 (7191) : 1138 - 1138
[2] BARER D, 1998, CEREBROVASC DIS, V8, P47
[3] Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials
Collins, R
MacMahon, S
[J]. LANCET, 2001, 357 (9253) : 373 - 380
[4] THE CLINICAL MEANING OF RANKIN HANDICAP GRADES AFTER STROKE
DEHAAN, R
LIMBURG, M
BOSSUYT, P
VANDERMEULEN, J
AARONSON, N
[J]. STROKE, 1995, 26 (11) : 2027 - 2030
[5] HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
[6] Bootstrap statistics of ECASS II data: Just another post hoc analysis of a negative stroke trial?
Stingele, R
Bluhmki, E
Hacke, W
[J]. CEREBROVASCULAR DISEASES, 2001, 11 (01) : 30 - 33
[7] VANGIJN J, 1992, CEREBROVASC DIS, V2, P244
[8] INTEROBSERVER AGREEMENT FOR THE ASSESSMENT OF HANDICAP IN STROKE PATIENTS
VANSWIETEN, JC
KOUDSTAAL, PJ
VISSER, MC
SCHOUTEN, HJA
VANGIJN, J
[J]. STROKE, 1988, 19 (05) : 604 - 607